UK-BioNTech partnership for mRNA cancer vaccines

Lancet Oncol. 2023 Aug;24(8):846. doi: 10.1016/S1470-2045(23)00339-X. Epub 2023 Jul 13.
No abstract available

Publication types

  • News

MeSH terms

  • Cancer Vaccines* / therapeutic use
  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / therapy
  • RNA, Messenger
  • United Kingdom

Substances

  • Cancer Vaccines
  • RNA, Messenger